GeneTex
United States (US)

EMAP II recombinant protein

Cat No. GTX65302

Application ELISA, Functional Assay, Apuri, Blocking
Reactivity Human
Species Human
APPLICATION

Application Note

Protein's bioactivity determined by its ability to induce apoptosis in MCF-7 cells using a concentration range of 20-40 ng/ml.

Calculated MW

18.3 kDa. ( Note )
PROPERTIES

Form

Lyophilized powder

Buffer

water containing 20 mM sodium Phosphate buffer pH7.5 and 130 mM sodium chloride.

Storage

Reconstitute in water to a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers. Stored at -20ºC for future use.

Antigen Species

Human

Expression System

E. coli

Purification


Purity was assessed by SDS-PAGE (≥98%) and by HPLC.

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

EMAP2, M, AIMP1, EMAPII, EMAP-2, SCYE1, p43, EMAP 2

Background

Endothelial-Monocyte Activating Polypeptide-II (EMAP-II) is a tumor derived cytokine that is an anti-angiogenic factor in tumor Vascular development, and strongly inhibits tumor growth. Recombinant human EMAP-II is an 18.3 kDa protein containing 166 amino acid residues.

Research Area